FUJI PHARMA CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,529 JPY | +0.72% |
|
-4.56% | -12.08% |
| 2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
| 2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
Evolution of the average Target Price on Fuji Pharma Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
e85336ccb1643d53b86d57a439a86.fIdcUehrLqu86vDSO09YLv2UzQV_hoktcIGz2T3Ovrk.F9gZG5ovbcTEm5WcYzhoZ5HutDUv9sxlF9f9slSC54wm0Bgfv1lN5cjfwA~47c908c972928f38613e3c2bb67f3b6b
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,518
JPY
Average target price
2,090
JPY
Spread / Average Target
+37.68%
High Price Target
2,270
JPY
Spread / Highest target
+49.54%
Low Price Target
2,000
JPY
Spread / Lowest Target
+31.75%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4554 Stock
- Consensus Fuji Pharma Co., Ltd.